mail
admin@editorjprims.com
whatsapp
+919343055451
e-ISSN: 3049-1681
logo

Journal of Pharmaceutical Research and Integrated Medical Sciences

Arpan Tripathi

Author Profile
FPS, SSTC, Bhilai, Chhattisgarh, India
2
Publications
2
Years Active
4
Collaborators
41
Citations

Publications by Arpan Tripathi

2 publications found • Active 2024-2025

2025

1 publication

Nanosome: As Carrier for Drug DeliveryV

with V Madhukar, D. K. Biswas
2025

Inquisitions made in the field of new delivery system leads to prevent various problem and difficulties associated with conventional therapy and could led to the development of several vesicular systems. Advancements in this field have led to the emergence of nanorange delivery system among which Nanosome have achieved the prime importance as they are not taken up by the RES by which the rapid clearance of the drug is inhibited, the major drawback associated with other vesicular systems. A Nanosome is a phospholipids Bilayer vesicle that is nanometer in size and made up of one or more lipid bilayers. Because they share molecular traits with mammalian cell membranes, they are generally non-toxic, non-antigenic, and biodegradable. The current review deals with the classification, properties, method of preparation, and mode of transport and characterization parameters of Nanosome with an overlook on its applications.

2024

1 publication

Preparation, Characterization, and Bio-Efficacy Evaluation of Controlled-Release Carbendazim-Loaded Polymeric Nanoparticles

with Rupesh Soni, Shekhar Verma
2024

This research discusses the bio-efficacy, characterization, and synthesis of polymeric nanoparticles (CNPs) charged with the fungicide carbendazim in controlled-release pest management applications for agriculture. The traditional usage of the broad-spectrum fungicide carbendazim has faced many disadvantages, such as its high toxicity, rapid environmental degradation, and resistance. Problems associated with carbendazim are resolved by CNPs encapsulating it, as the regulated release profile enhances the stability of the fungicide and diminishes its negative impact on the environment. They possessed excellent physicochemical characteristics, such as a stable surface charge of (-25.6 ± 0.9 mV), a high encapsulation efficiency of (82 ± 2%), and an optimal particle size of (150 ± 10 nm), respectively, which were achieved by using a solvent evaporation approach to manufacture the nanoparticles. Carbendazepim release from CNPs presented a slow, steady release over 120 hours and a far lower burst release 77.8% less than the standard formulation. Comparison of the traditional carbendazim against CNPs showed an improvement of 28.6% in bio-efficacy. The wider inhibition zones and better reduction in mycelial growth indicate superior antifungal action. These results highlight the advantages of polymeric nanoparticles as a sustainable and environmentally friendly substitute.